MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.3 0.02 (0.63%) --- --- --- -0.05 (-1.49%) 0.14 (4.18%) -0.06 (-1.78%) -0.06 (-1.78%)

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.27
Diluted EPS:
-0.27
Basic P/E:
-12.2963
Diluted P/E:
-12.2963
RSI(14) 1m:
0.0
VWAP:
3.32
RVol:
0.7103

Events

Period Kind Movement Occurred At
1m Price increase 1m 3.28 +0.05 (+1.55%) Oct 15 09:30

Related News